PDS Biotechnology Corp (PDSB)

Latest Insider Confidence Score

2026Q1

50.0
Bullish

Company insider confidence (by quarter)

2015Q3 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Ratcliffe Liam — 2,344,868 Mar 18, 2019
New Leaf Ventures III, L.P. — 2,344,868 Jun 23, 2016
New Leaf Venture Associates III, L.P. — 2,344,868 Jun 23, 2016
New Leaf Venture Management III, L.L.C. — 2,344,868 Jun 23, 2016
Hove Anders D Director 1,571,917 Oct 8, 2015

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 12, 2026 Mar 3, 2026 BEDU-ADDO FRANK CEO Neutral 52.5 - 0.00% ✗ -
Jan 12, 2026 Mar 3, 2026 CONN GREGORY Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Jan 12, 2026 Mar 3, 2026 Shepard Kirk V. Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jan 12, 2026 Mar 3, 2026 Boesgaard Lars CFO Neutral 52.5 - 0.00% ✗ -
Jan 12, 2026 Mar 3, 2026 Brown Spencer D. Senior VP, General Counsel Neutral 52.5 - 0.00% ✗ -
Jan 12, 2026 Mar 3, 2026 Toutain Stephan COO Neutral 52.5 - 0.00% ✗ -
Jan 12, 2026 Mar 3, 2026 Freitag Gregory Gene Director Neutral 52.5 - 0.00% ✗ -
Jan 12, 2026 Mar 3, 2026 Iliev Ilian Director Neutral 52.5 - 0.00% ✗ -
Jan 12, 2026 Mar 3, 2026 Ali-Jackson Kamil Director Neutral 52.5 - 0.00% ✗ -
Jan 12, 2026 Mar 3, 2026 BRAWLEY OTIS W Director Neutral 52.5 - 0.00% ✗ -
Jan 12, 2026 Mar 3, 2026 Glover Stephen C. Director Neutral 52.5 - 0.00% ✗ -
Feb 28, 2024 Jul 25, 2025 BEDU-ADDO FRANK CEO Neutral 52.5 - 0.00% ✗ -
Jun 12, 2025 Jul 25, 2025 Shepard Kirk V. Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Feb 28, 2024 Jul 25, 2025 Brown Spencer D. Senior VP, General Counsel Neutral 52.5 - 0.00% ✗ -
Jun 12, 2025 Jul 25, 2025 Boesgaard Lars CFO Neutral 52.5 - 0.00% ✗ -
Feb 28, 2024 Jul 25, 2025 CONN GREGORY Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Jun 12, 2025 Jul 25, 2025 Toutain Stephan Chief Operations Officer Neutral 52.5 - 0.00% ✗ -
Jun 11, 2025 Jun 11, 2025 BRAWLEY OTIS W Director Neutral 52.5 - 0.00% ✗ -
Jun 11, 2025 Jun 11, 2025 Ali-Jackson Kamil Director Neutral 52.5 - 0.00% ✗ -
Jun 11, 2025 Jun 11, 2025 Freitag Gregory Gene Director Neutral 52.5 - 0.00% ✗ -
Jun 11, 2025 Jun 11, 2025 Iliev Ilian Director Neutral 52.5 - 0.00% ✗ -
Jun 11, 2025 Jun 11, 2025 Glover Stephen C. Director Neutral 52.5 - 0.00% ✗ -
Feb 28, 2025 Mar 3, 2025 Freitag Gregory Gene Director Buy 91.3 +15,060 32.63% ✗ $25K
Feb 28, 2025 Mar 3, 2025 Glover Stephen C. Director Buy 91.3 +15,061 23.61% ✗ $25K
Jun 24, 2024 Jun 25, 2024 Freitag Gregory Gene Director Neutral 52.5 - 0.00% ✗ -
Jun 24, 2024 Jun 25, 2024 Glover Stephen C. Director Neutral 52.5 - 0.00% ✗ -
Jun 24, 2024 Jun 25, 2024 SYKES RICHARD Director Neutral 52.5 - 0.00% ✗ -
Jun 24, 2024 Jun 25, 2024 Iliev Ilian Director Neutral 52.5 - 0.00% ✗ -
Jun 24, 2024 Jun 25, 2024 BRAWLEY OTIS W Director Neutral 52.5 - 0.00% ✗ -
Jun 24, 2024 Jun 25, 2024 Ali-Jackson Kamil Director Neutral 52.5 - 0.00% ✗ -
May 1, 2024 May 2, 2024 Toutain Stephan Chief Operations Officer Neutral 52.5 - 0.00% ✗ -
May 2, 2024 Toutain Stephan Chief Operations Officer Neutral 52.5 - 0.00% ✗ -
Jan 22, 2024 Jan 23, 2024 Shepard Kirk V. Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jan 23, 2024 Shepard Kirk V. Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Dec 4, 2023 Dec 4, 2023 Boesgaard Lars CFO Neutral 52.5 - 0.00% ✗ -
Dec 4, 2023 Boesgaard Lars CFO Neutral 52.5 - 0.00% ✗ -
Jul 14, 2023 Jul 17, 2023 Freitag Gregory Gene Director Neutral 52.5 - 0.00% ✗ -
Jul 14, 2023 Jul 17, 2023 BRAWLEY OTIS W Director Neutral 52.5 - 0.00% ✗ -
Jul 14, 2023 Jul 17, 2023 Ali-Jackson Kamil Director Neutral 52.5 - 0.00% ✗ -
Jul 14, 2023 Jul 17, 2023 SYKES RICHARD Director Neutral 52.5 - 0.00% ✗ -
Jul 14, 2023 Jul 17, 2023 Glover Stephen C. Director Neutral 52.5 - 0.00% ✗ -
Jul 14, 2023 Jul 17, 2023 Iliev Ilian Director Neutral 52.5 - 0.00% ✗ -
Jan 5, 2023 Jan 6, 2023 Brown Spencer D. Senior VP, General Counsel Neutral 52.5 - 0.00% ✗ -
Jan 5, 2023 Jan 6, 2023 HILL MATTHEW C CFO Neutral 52.5 - 0.00% ✗ -
Jan 5, 2023 Jan 6, 2023 CONN GREGORY Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Jan 5, 2023 Jan 6, 2023 BEDU-ADDO FRANK CEO Neutral 52.5 - 0.00% ✗ -
Jan 5, 2023 Jan 6, 2023 WOOD LAUREN Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Dec 2, 2022 Dec 2, 2022 BEDU-ADDO FRANK CEO Sell 17.5 -175,184 -20.23% ✗ $1.7M
Jun 28, 2022 Jun 29, 2022 Glover Steve C Director Neutral 52.5 - 0.00% ✗ -
Jun 28, 2022 Jun 29, 2022 Iliev Ilian Director Neutral 52.5 - 0.00% ✗ -
Jun 28, 2022 Jun 29, 2022 BRAWLEY OTIS W Director Neutral 52.5 - 0.00% ✗ -
Jun 28, 2022 Jun 29, 2022 Freitag Gregory Gene Director Neutral 52.5 - 0.00% ✗ -
Jun 28, 2022 Jun 29, 2022 SYKES RICHARD Director Neutral 52.5 - 0.00% ✗ -
Jun 28, 2022 Jun 29, 2022 Ali-Jackson Kamil Director Neutral 52.5 - 0.00% ✗ -
Jun 2, 2022 Jun 3, 2022 Brown Spencer D. Senior VP, General Counsel Neutral 52.5 - 0.00% ✗ -
Jun 3, 2022 Brown Spencer D. Senior VP, General Counsel Neutral 52.5 - 0.00% ✗ -
Jan 19, 2022 Jan 20, 2022 CONN GREGORY Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Jan 19, 2022 Jan 20, 2022 BEDU-ADDO FRANK CEO Neutral 52.5 - 0.00% ✗ -
Jan 19, 2022 Jan 20, 2022 WOOD LAUREN Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Dec 13, 2021 Dec 14, 2021 HILL MATTHEW C CFO Buy 91.3 +3,100 35.13% ✗ $27.9K
Oct 19, 2021 Oct 20, 2021 HILL MATTHEW C CFO Neutral 52.5 - 0.00% ✗ -
Oct 20, 2021 HILL MATTHEW C CFO Neutral 52.5 - 0.00% ✗ -
Oct 12, 2021 Trochimiuk Janetta Principal Accounting Officer Neutral 52.5 - 0.00% ✗ -
Jun 16, 2021 Jun 21, 2021 Bloomquist DeLyle W Other Buy 82.5 +10,000 1.27% ✗ $98.8K
Jun 15, 2021 Jun 17, 2021 BEDU-ADDO FRANK CEO Sell 20.0 -27,166 -4.03% ✗ $349.4K
Jun 17, 2021 Jun 17, 2021 BRAWLEY OTIS W Director Neutral 52.5 - 0.00% ✗ -
Jun 15, 2021 Jun 17, 2021 Glover Steve C Director Buy 91.3 +5,882 10.16% ✗ $50K
Jun 15, 2021 Jun 17, 2021 Ali-Jackson Kamil Director Buy 95.0 +11,764 100.00% ✗ $100K
Jun 17, 2021 Jun 17, 2021 SYKES RICHARD Director Neutral 52.5 - 0.00% ✗ -
Jun 17, 2021 Jun 17, 2021 Iliev Ilian Director Neutral 52.5 - 0.00% ✗ -
Jun 15, 2021 Jun 17, 2021 VAN VOORHEES SETH CFO Buy 95.0 +17,647 100.00% ✗ $150K
Jun 15, 2021 Jun 17, 2021 Freitag Gregory Gene Director Buy 91.3 +5,882 14.61% ✗ $50K
Jan 4, 2021 Jan 6, 2021 VAN VOORHEES SETH CFO Neutral 52.5 - 0.00% ✗ -
Jan 6, 2021 VAN VOORHEES SETH CFO Neutral 52.5 - 0.00% ✗ -
Dec 8, 2020 Dec 9, 2020 CONN GREGORY Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Dec 8, 2020 Dec 9, 2020 WOOD LAUREN Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Dec 8, 2020 Dec 9, 2020 King Michael N. CFO Neutral 52.5 - 0.00% ✗ -
Dec 8, 2020 Dec 9, 2020 BEDU-ADDO FRANK CEO Neutral 52.5 - 0.00% ✗ -
Nov 3, 2020 Nov 6, 2020 BRAWLEY OTIS W Director Neutral 52.5 - 0.00% ✗ -
Nov 6, 2020 BRAWLEY OTIS W Director Neutral 52.5 - 0.00% ✗ -
Jul 6, 2020 King Michael N. CFO Neutral 52.5 - 0.00% ✗ -
Jun 23, 2020 Jun 25, 2020 Glover Steve C Director Neutral 52.5 - 0.00% ✗ -
Jun 23, 2020 Jun 25, 2020 Freitag Gregory Gene Director Neutral 52.5 - 0.00% ✗ -
Jun 23, 2020 Jun 25, 2020 SYKES RICHARD Director Neutral 52.5 - 0.00% ✗ -
Jun 23, 2020 Jun 25, 2020 Ali-Jackson Kamil Director Neutral 52.5 - 0.00% ✗ -
Jun 23, 2020 Jun 25, 2020 WOOD LAUREN Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jun 23, 2020 Jun 25, 2020 Bloomquist DeLyle W Director Neutral 52.5 - 0.00% ✗ -
Jun 23, 2020 Jun 25, 2020 Iliev Ilian Director Neutral 52.5 - 0.00% ✗ -
Jun 23, 2020 Jun 25, 2020 CONN GREGORY Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Jun 23, 2020 Jun 25, 2020 BEDU-ADDO FRANK CEO Neutral 52.5 - 0.00% ✗ -
Apr 8, 2020 Apr 9, 2020 Iliev Ilian Director Neutral 52.5 - 0.00% ✗ -
Apr 9, 2020 Iliev Ilian Director Neutral 52.5 - 0.00% ✗ -
Mar 25, 2020 Trochimiuk Janetta Principal Accounting Officer Neutral 52.5 - 0.00% ✗ -
Feb 21, 2020 Feb 24, 2020 Ali-Jackson Kamil Director Neutral 52.5 - 0.00% ✗ -
Feb 24, 2020 Ali-Jackson Kamil Director Neutral 52.5 - 0.00% ✗ -
Feb 14, 2020 Feb 19, 2020 Freitag Gregory Gene Director Neutral 90.0 +38,400 2052.38% ✗ -
Feb 14, 2020 Feb 19, 2020 SYKES RICHARD Director Neutral 90.0 +384,615 635.80% ✗ -
Feb 14, 2020 Feb 19, 2020 Saik Andrew CFO Neutral 90.0 +38,400 925.52% ✗ -
Feb 14, 2020 Feb 19, 2020 Glover Steve C Director Neutral 90.0 +38,400 196.84% ✗ -
Jun 28, 2019 Jul 1, 2019 Glover Steve C Director Neutral 52.5 - 0.00% ✗ -